Grand Pharmaceutical Group Limited (HKG:0512)
Hong Kong
· Delayed Price · Currency is HKD 6.41
+0.08 (1.26%)
Apr 29, 2026, 4:08 PM HKT
HKG:0512 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 22,447 | 27,489 | 16,809 | 14,394 | 16,225 | 22,930 | Upgrade
|
| Market Cap Growth | 2.07% | 63.54% | 16.78% | -11.29% | -29.24% | -6.11% | Upgrade
|
| Enterprise Value | 24,433 | 29,899 | 18,299 | 16,581 | 18,124 | 22,786 | Upgrade
|
| Last Close Price | 6.41 | 7.85 | 4.59 | 3.71 | 4.04 | 5.53 | Upgrade
|
| PE Ratio | 18.09 | 22.15 | 6.81 | 7.66 | 7.80 | 9.54 | Upgrade
|
| Forward PE | 13.35 | 11.94 | 8.11 | 7.31 | 7.90 | 9.61 | Upgrade
|
| PS Ratio | 1.83 | 2.24 | 1.44 | 1.37 | 1.70 | 2.67 | Upgrade
|
| PB Ratio | 1.31 | 1.60 | 1.02 | 0.94 | 1.14 | 1.71 | Upgrade
|
| P/TBV Ratio | 1.86 | 2.28 | 1.28 | 1.12 | 1.34 | 1.95 | Upgrade
|
| P/FCF Ratio | - | - | 12.52 | 7.43 | 13.34 | 14.95 | Upgrade
|
| P/OCF Ratio | - | - | 8.86 | 5.94 | 8.81 | 11.43 | Upgrade
|
| EV/Sales Ratio | 1.99 | 2.43 | 1.57 | 1.58 | 1.90 | 2.65 | Upgrade
|
| EV/EBITDA Ratio | 10.63 | 13.45 | 6.84 | 5.16 | 5.83 | 9.14 | Upgrade
|
| EV/EBIT Ratio | 13.24 | 16.90 | 8.24 | 5.80 | 6.60 | 10.50 | Upgrade
|
| EV/FCF Ratio | - | - | 13.63 | 8.56 | 14.90 | 14.85 | Upgrade
|
| Debt / Equity Ratio | 0.28 | 0.28 | 0.27 | 0.22 | 0.32 | 0.27 | Upgrade
|
| Debt / EBITDA Ratio | 2.13 | 2.13 | 1.63 | 1.05 | 1.42 | 1.46 | Upgrade
|
| Debt / FCF Ratio | - | - | 3.31 | 1.76 | 3.68 | 2.38 | Upgrade
|
| Net Debt / Equity Ratio | 0.11 | 0.11 | 0.04 | 0.01 | 0.08 | 0.01 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.82 | 0.82 | 0.27 | 0.04 | 0.37 | 0.06 | Upgrade
|
| Net Debt / FCF Ratio | - | - | 0.53 | 0.07 | 0.94 | 0.10 | Upgrade
|
| Asset Turnover | 0.47 | 0.47 | 0.49 | 0.47 | 0.44 | 0.45 | Upgrade
|
| Inventory Turnover | 3.86 | 3.86 | 3.56 | 2.94 | 2.94 | 3.23 | Upgrade
|
| Quick Ratio | 0.93 | 0.93 | 1.01 | 0.98 | 0.86 | 1.00 | Upgrade
|
| Current Ratio | 1.14 | 1.14 | 1.22 | 1.22 | 1.07 | 1.22 | Upgrade
|
| Return on Equity (ROE) | 7.38% | 7.38% | 15.51% | 12.86% | 15.18% | 19.41% | Upgrade
|
| Return on Assets (ROA) | 4.24% | 4.24% | 5.84% | 7.96% | 7.91% | 7.13% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.75% | 8.13% | 11.77% | 15.04% | 15.83% | 15.13% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.90% | 8.90% | 12.10% | 17.00% | 17.30% | 14.00% | Upgrade
|
| Earnings Yield | 5.53% | 4.51% | 14.69% | 13.06% | 12.82% | 10.48% | Upgrade
|
| FCF Yield | - | - | 7.99% | 13.46% | 7.50% | 6.69% | Upgrade
|
| Dividend Yield | 2.67% | 2.15% | 5.67% | 7.01% | 3.46% | 1.99% | Upgrade
|
| Payout Ratio | - | - | 36.88% | 26.43% | 18.78% | 16.25% | Upgrade
|
| Buyback Yield / Dilution | - | - | 0.17% | 0.97% | 0.16% | -2.98% | Upgrade
|
| Total Shareholder Return | 2.67% | 2.15% | 5.83% | 7.99% | 3.62% | -1.00% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.